Company: CNTB
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001835268-25-000014
Chunk: 281

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-03-31
Form: 10-K
Item: Item 8
Chunk 281
---
 investments15,476 12,640 Prepaid expenses and other current assets555 706 Amounts due from subsidiaries13,078 12,997 Investments in subsidiaries27,484 4,604 Total assets$103,658 $110,200 LIABILITIES AND SHAREHOLDERS' EQUITYLiabilities:Accounts payable and accrued liabilities$117 $586 Amounts due to subsidiaries10,875 7,867 Other non-current liabilities500 250 Total liabilities11,492 8,703 Total shareholders' equity92,166 101,497 Total liabilities and shareholders' equity$103,658 $110,200 Condensed Statement of Operations and Comprehensive Loss(in thousands)

132

Years Ended December 31,20242023General and administrative expense$(6,010)$(5,412)Interest income3,893 4,608 Equity losses of subsidiaries(13,511)(61,302)Net Loss attributable to Connect Biopharma Holdings Limited shareholders(15,628)(62,106)Other comprehensive loss:Foreign currency translation adjustments(670)(614)Unrealized gains on available-for-sale investments12 354 Comprehensive loss attributable to Connect Biopharma Holdings Limited shareholders$(16,286)$(62,366)Condensed Statement of Cash Flows(in thousands)Years Ended December 31,20242023Net cash used in operating activities$(2,110)$(771)Net cash (used in) provided by investing activities(30,305)32,070 Net cash provided by financing activities227 45 Net (decrease) increase in cash and cash equivalents(32,188)31,344 Cash and cash equivalents at beginning of year79,253 47,909 Cash and cash equivalents at end of year$47,065 $79,253 During the years ended December 31, 2024 and 2023, no cash dividend was declared and paid by the parent company.As of December 31, 2024, there were no material contingencies, significant provisions of long-term obligations, and mandatory dividend or redemption requirements of redeemable shares or guarantees of the parent company, except for those which have been separately disclosed in the Consolidated Financial Statement, if any.Basis of preparationThe condensed financial information of the parent company has been prepared using the same accounting policies as set out in its consolidated financial statements, except that the parent company has used the equity method to account